Clinical distribution and drug-resistance analysis of Acinetobacter baumannii isolated from our hospital in 2014
10.3969/j.issn.1673-4130.2016.09.016
- VernacularTitle:某院2014年鲍曼不动杆菌感染的临床分布及耐药性分析
- Author:
Tingdong ZHOU
;
Zhou LIU
;
Shihe GUAN
- Publication Type:Journal Article
- Keywords:
intensive care unit;
Acinetobacter baumannii;
detection rate;
resistance rate
- From:
International Journal of Laboratory Medicine
2016;37(9):1195-1196,1199
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the clinical characteristics of acinetobacter baumannii infection and drug resistance tendency of our hospital in 2014 ,so as to promote the clinical rational use of antibiotics .Methods The study was a retrospective review ,the re‐sults of clinical distribution and drug resistance of acinetobacter baumannii isolated from our hospital in 2014 were analyzed .The an‐timicrobial susceptibility testing(AST) of acinetobacter baumannii was determined by K‐B disk diffusion method and minimal inhib‐itory concentration(MIC) test ,respectively .The AST was performed as recommended by CLSI 2010 .Results A total of 299 strains of acinetobacter baumannii were isolated from clinical specimens throughout the year .Of the 299 Acinetobacter baumannii isolates , 268 strains(89 .63% ) were isolated from sputum ,165 strains(55 .18% ) of Acinetobacter baumannii were from intensive care unit (ICU) and 52 strains(17 .39% ) were from neurosurgery .The resistance rate of Acinetobacter baumannii to cefoperazone/sulbactam was 5 .02% while its resistance to Imipenem and Meropenem significantly increased to 52 .17% and 56 .86% ,respectively .And the resistance rates ofβ‐lactams ,fluoroquinolones and aminoglycosides were higher than 60% .Conclusion The isolation rate of Acine‐tobacter baumannii is increasing in recent year in our hospital ,as well the resistance rate to the common Antibiotics .Monitoring the resistance of Acinetobacter baumannii should be strengthened for preventing resistant bacteria from spreading .
